Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.

Auditory processing Autism spectrum disorder Change detection EEG Habituation Neurofibromatosis type 1

Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
28 05 2021
Historique:
received: 16 06 2020
accepted: 03 04 2021
entrez: 29 5 2021
pubmed: 30 5 2021
medline: 27 8 2021
Statut: epublish

Résumé

Sensory modulation difficulties are common in children with conditions such as Autism Spectrum Disorder (ASD) and could contribute to other social and non-social symptoms. Positing a causal role for sensory processing differences requires observing atypical sensory reactivity prior to the emergence of other symptoms, which can be achieved through prospective studies. In this longitudinal study, we examined auditory repetition suppression and change detection at 5 and 10 months in infants with and without Neurofibromatosis Type 1 (NF1), a condition associated with higher likelihood of developing ASD. In typically developing infants, suppression to vowel repetition and enhanced responses to vowel/pitch change decreased with age over posterior regions, becoming more frontally specific; age-related change was diminished in the NF1 group. Whilst both groups detected changes in vowel and pitch, the NF1 group were largely slower to show a differentiated neural response. Auditory responses did not relate to later language, but were related to later ASD traits. These findings represent the first demonstration of atypical brain responses to sounds in infants with NF1 and suggest they may relate to the likelihood of later ASD.

Sections du résumé

BACKGROUND
Sensory modulation difficulties are common in children with conditions such as Autism Spectrum Disorder (ASD) and could contribute to other social and non-social symptoms. Positing a causal role for sensory processing differences requires observing atypical sensory reactivity prior to the emergence of other symptoms, which can be achieved through prospective studies.
METHODS
In this longitudinal study, we examined auditory repetition suppression and change detection at 5 and 10 months in infants with and without Neurofibromatosis Type 1 (NF1), a condition associated with higher likelihood of developing ASD.
RESULTS
In typically developing infants, suppression to vowel repetition and enhanced responses to vowel/pitch change decreased with age over posterior regions, becoming more frontally specific; age-related change was diminished in the NF1 group. Whilst both groups detected changes in vowel and pitch, the NF1 group were largely slower to show a differentiated neural response. Auditory responses did not relate to later language, but were related to later ASD traits.
CONCLUSIONS
These findings represent the first demonstration of atypical brain responses to sounds in infants with NF1 and suggest they may relate to the likelihood of later ASD.

Identifiants

pubmed: 34049498
doi: 10.1186/s11689-021-09364-3
pii: 10.1186/s11689-021-09364-3
pmc: PMC8161667
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Subventions

Organisme : Medical Research Council
ID : MR/T003057/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401546
Pays : United Kingdom

Investigateurs

Rebecca Holman (R)
Sarah Kalwarowsky (S)
Laura Pirazzoli (L)
Chloë Taylor (C)
Grace Vassallo (G)
Emma Burkitt-Wright (E)
Judith Eelloo (J)
D Gareth Evans (DG)
Siobhan West (S)
Eileen Hupton (E)
Lauren Lewis (L)
Louise Robinson (L)
Angus Dobbie (A)
Ruth Drimer (R)
Saghira Malik Sharif (SM)
Helen Bethell (H)
Rachel Jones (R)
Susan Musson (S)
Catherine Prem (C)
Miranda Splitt (M)
Karen Horridge (K)
Diana Baralle (D)
Carolyn Redman (C)
Helen Tomkins (H)

Références

J Pediatr Psychol. 2002 Jan-Feb;27(1):37-45
pubmed: 11726678
Dev Med Child Neurol. 2013 Feb;55(2):139-45
pubmed: 23163236
Child Dev. 2021 May;92(3):1187-1198
pubmed: 33368222
Pediatr Neurol. 2017 Oct;75:80-86
pubmed: 28844798
J Cogn Neurosci. 2005 Jul;17(7):1168-80
pubmed: 16138434
J Cogn Neurosci. 2007 May;19(5):878-92
pubmed: 17488211
Autism Res. 2009 Jun;2(3):125-37
pubmed: 19582867
J Autism Dev Disord. 2007 May;37(5):894-910
pubmed: 17016677
Am J Med Genet A. 2010 Feb;152A(2):327-32
pubmed: 20082463
J Commun Disord. 2007 Jul-Aug;40(4):275-83
pubmed: 17420028
J Pediatr. 2006 Sep;149(3):348-53
pubmed: 16939745
Transl Psychiatry. 2016 Apr 19;6:e787
pubmed: 27093069
Annu Rev Neurosci. 2010;33:221-43
pubmed: 20345245
Biol Psychiatry. 2019 Aug 15;86(4):294-305
pubmed: 31272685
J Neurodev Disord. 2014;6(1):43
pubmed: 25937843
Ear Hear. 1995 Feb;16(1):38-51
pubmed: 7774768
Dev Sci. 2013 Mar;16(2):287-295
pubmed: 23432837
Child Neuropsychol. 2000 Sep;6(3):185-94
pubmed: 11402396
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
Brain Cogn. 2018 Jun;123:110-119
pubmed: 29550506
Mol Autism. 2014 Mar 12;5(1):23
pubmed: 24618368
J Neurodev Disord. 2018 Jan 29;10(1):4
pubmed: 29378522
J Autism Dev Disord. 2015 Nov;45(11):3656-67
pubmed: 26111738
Neuroreport. 2011 Nov 16;22(16):845-9
pubmed: 21934535
Res Autism Spectr Disord. 2012 Winter;6(1):337-344
pubmed: 22059092
Nat Rev Neurosci. 2017 Nov;18(11):671-684
pubmed: 28951611
Dev Med Child Neurol. 2013 Feb;55(2):131-8
pubmed: 23163951
Dev Psychopathol. 2015 May;27(2):425-42
pubmed: 25997763
Neurosci Biobehav Rev. 2014 Feb;39:1-33
pubmed: 24361967
J Neurodev Disord. 2016 Jul 26;8:26
pubmed: 27516813
Neuroreport. 2008 Jan 8;19(1):79-82
pubmed: 18281897
Psychophysiology. 1994 Sep;31(5):495-502
pubmed: 7972604
Curr Biol. 2015 Jun 29;25(13):1727-30
pubmed: 26073135
J Med Genet. 1995 Dec;32(12):921-4
pubmed: 8825915
Sleep Med Rev. 2007 Aug;11(4):277-93
pubmed: 17628317
Behav Brain Res. 2002 Oct 17;136(1):31-49
pubmed: 12385788
Bioessays. 2019 Sep;41(9):e1900077
pubmed: 31429094
J Pers Assess. 2014;96(4):445-58
pubmed: 24206185
Psychophysiology. 1990 Nov;27(6):627-40
pubmed: 2100348
PLoS One. 2011 May 09;6(5):e18993
pubmed: 21573058
Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):72-80
pubmed: 25388972
Dev Psychobiol. 2002 Apr;40(3):278-92
pubmed: 11891639
J Commun Disord. 2014 Mar-Apr;48:18-26
pubmed: 24447521
Cereb Cortex. 2005 May;15(5):545-51
pubmed: 15342438
Neuroreport. 2000 Sep 28;11(14):3109-12
pubmed: 11043532
Clin Neurophysiol. 2000 Jan;111(1):4-16
pubmed: 10656505
Psychophysiology. 2000 Nov;37(6):807-16
pubmed: 11117461
Child Dev. 2004 Jul-Aug;75(4):1067-84
pubmed: 15260865
Biol Psychiatry. 2003 Mar 15;53(6):511-9
pubmed: 12644356
J Child Psychol Psychiatry. 2019 Sep;60(9):963-974
pubmed: 29963709
Clin Electroencephalogr. 1991 Jan;22(1):40-5
pubmed: 1991411
Dev Cogn Neurosci. 2018 Jan;29:4-10
pubmed: 27769716
J Atten Disord. 2017 Feb;21(3):209-218
pubmed: 23757333
Autism Res. 2013 Dec;6(6):605-13
pubmed: 23929787
Psychophysiology. 1991 Mar;28(2):240-4
pubmed: 1946890
Trends Genet. 1989 Jul;5(7):217-21
pubmed: 2506682
J Autism Dev Disord. 2015 Jun;45(6):1649-57
pubmed: 25475362
J Integr Neurosci. 2005 Mar;4(1):63-76
pubmed: 16035141
Am J Med Genet C Semin Med Genet. 2015 Jun;169(2):198-208
pubmed: 25959391
Genet Med. 2010 Jan;12(1):1-11
pubmed: 20027112
Clin Neurophysiol. 2006 Mar;117(3):496-503
pubmed: 16426892
Transl Psychiatry. 2019 Jan 30;9(1):46
pubmed: 30700699
PLoS One. 2014 Mar 18;9(3):e92372
pubmed: 24643088
Nat Commun. 2018 May 7;9(1):1678
pubmed: 29735992
Neuropsychopharmacology. 2008 Jun;33(7):1680-9
pubmed: 17712349
J Neurodev Disord. 2010 Jun;2(2):62-9
pubmed: 22127855
Dialogues Clin Neurosci. 2012 Sep;14(3):281-92
pubmed: 23226953
Neuroreport. 1998 Jun 1;9(8):1885-8
pubmed: 9665620
Clin Neurophysiol. 2000 Feb;111(2):220-36
pubmed: 10680557
J Autism Dev Disord. 2008 Apr;38(4):731-8
pubmed: 17874180
Dev Cogn Neurosci. 2018 Jan;29:117-126
pubmed: 28223033
Neurosci Lett. 2008 Mar 28;434(2):218-23
pubmed: 18313850
Pediatrics. 2013 Dec;132(6):e1642-8
pubmed: 24190681
Brain Res. 2019 Mar 1;1706:157-165
pubmed: 30392771
Sleep. 1999 May 1;22(3):320-6
pubmed: 10341382
Neurology. 2005 Oct 11;65(7):1037-44
pubmed: 16217056
J Exp Child Psychol. 1970 Apr;9(2):208-16
pubmed: 5452115
J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):256-66.e1-2
pubmed: 20410715
Mol Autism. 2017 Sep 19;8:47
pubmed: 28932379
Trends Biochem Sci. 1998 Jul;23(7):257-62
pubmed: 9697416
Neuroreport. 2003 Apr 15;14(5):693-7
pubmed: 12692465
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8722-6
pubmed: 8378354
Can J Psychol. 1989 Jun;43(2):230-46
pubmed: 2486497
Behaviour. 1973;47(1):1-13
pubmed: 4758853
J Neurodev Disord. 2009 Jun;1(2):114-32
pubmed: 21547711
Nature. 2002 Jan 31;415(6871):526-30
pubmed: 11793011
J Autism Dev Disord. 2013 Mar;43(3):673-86
pubmed: 22918859
JAMA Psychiatry. 2013 Jan;70(1):42-8
pubmed: 22945359
Elife. 2018 Oct 26;7:
pubmed: 30362457
Brain Topogr. 2014 Jul;27(4):451-66
pubmed: 24838819
Mol Autism. 2013 Sep 04;4(1):31
pubmed: 24007557
Child Neuropsychol. 2018 May;24(4):558-574
pubmed: 28393676
J Autism Dev Disord. 2017 Oct;47(10):3125-3138
pubmed: 28688078
Hum Brain Mapp. 2012 Mar;33(3):596-608
pubmed: 21488136
Neuroreport. 2002 Oct 28;13(15):1843-8
pubmed: 12395076
Front Cell Neurosci. 2019 Aug 20;13:385
pubmed: 31481879
Neuroreport. 2002 Jan 21;13(1):47-51
pubmed: 11924892
J Intellect Disabil Res. 2016 Jan;60(1):54-67
pubmed: 26449367
Child Dev. 1993 Feb;64(1):57-79
pubmed: 8436038
Genes Brain Behav. 2003 Oct;2(5):255-67
pubmed: 14606691
Front Cell Neurosci. 2019 Feb 19;13:57
pubmed: 30837845
J Autism Dev Disord. 2020 Feb;50(2):603-616
pubmed: 31728809

Auteurs

Jannath Begum-Ali (J)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK. jannath.begum@bbk.ac.uk.

Anna Kolesnik-Taylor (A)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK.
Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK.

Isabel Quiroz (I)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK.

Luke Mason (L)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK.

Shruti Garg (S)

Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Jonathan Green (J)

Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.

Mark H Johnson (MH)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK.
Department of Psychology, University of Cambridge, Cambridge, UK.

Emily J H Jones (EJH)

Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, Malet Street, London, WC1E 7HX, UK. e.jones@bbk.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH